Customized treatment of recurrent gynaecological cancer - the need for intraoperative radiation therapy

Objective: The objective of this retrospective study was to analyze the experience with intraoperative radiation therapy (IORT) at the present institution and to evaluate its contribution to the management of patients with recurrent gynecological cancer. Materials and Methods: Retrospectively this study reviewed data of patients with a gynecological malignancy considered for treatment with IORT at Freiburg University Medical Center between 2005 and 2012. For this purpose, an analysis of medical records, radiation oncology records, operation reports, and follow-up data was conducted. Results: During the period of this study, 31 women with gynecological cancer underwent tumor resection in combination with IORT. The median age of the patients at the time of IORT was 62 years (range 38-85). Most patients had undergone surgery at the time of initial diagnosis (87%). More than one-third of the patients received prior radiation therapy. In addition to that, 52% of the patients had already received chemotherapy. The majority of patients suffered from the first relapse of their disease. The local recurrence was predominantly located at the pelvic side wall (32%) or in intra-abdominal lymph nodes (32%). In 12 patients the authors did not apply the planned IORT. Intraoperative complications were rare and IORT was tolerated without severe side-effects. Follow-up was 14 months (range 1-65), progression free survival (PFS) was five months (range 3-31). Conclusions: In carefully selected patients, IORT and cytoreductive surgery contributed to local control and disease palliation. The authors therefore consider IORT an important aspect of modern cancer treatment.

Intraoperative radiation therapy (IORT); Recurrent gynecological cancer; Surgery.

[1] del Carmen M.G., McIntyre J.F., Goodman A.: The role of intraoperative radiation therapy (IORT) in the treatment of locally advanced gynecologic malignancies”. Oncologist, 2000, 5, 18.

[2] Haas T., Buchsbaum H.J., Lifshitz S.: “Nonresectable recurrent pelvic neoplasm: outcome in patients explored for pelvic exenteration”. Gynecol. Oncol., 1980, 9, 177.

[3] Gemignani M.L., Alektiar K.M., Leitao M., Mychalczak B., Chi D., Venkatraman E., et al.: “Radical surgical resection and high-dose intraoperative radiation therapy (HDR-IORT) in patients with recurrent gynecologic cancers”. Int. J. Radiat. Oncol. Biol. Phys., 2001, 50, 687.

[4] Goldberg G.L., Sukumvanich P., Einstein M.H., Smith H.O., Anderson P.S., Fields A.L.: “Total pelvic exenteration: The Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987 to 2003)”. Gynecol. Oncol., 2006, 101, 261.

[5] Berek J.S., Howe C., Lagasse L.D., Hacker N.F.: “Pelvic exenteration for recurrent gynecologic malignancy: Survival and morbidity analysis of the 45-year experience at UCLA”. Gynecol. Oncol., 2005, 99, 153.

[6] Morley G.W., Hopkins M.P., Lindenauer S.M., Roberts J.A.: Pelvic exenteration, University of Michigan: 100 patients at 5 years”. Obstet. Gynecol., 1989, 74, 934.

[7] del Carmen M.G., McIntyre J.F., Fuller A.F., Nikrui N., Goodman A.: “Intraoperative radiation therapy in the treatment of pelvic gynecologic malignancies: a review of fifteen cases”. Gynecol. Oncol., 2000, 79, 457.

[8] Gunderson L.L.: “Rationale for and results of intraoperative radiation therapy”. Cancer, 1994, 74, 537.

[9] Haddock M.G., Martinez-Monge R., Peterson I.A., Wilson T.O.: “Locally advanced primary and recurrent gynecologic malignancies. EBRT with or without IOERT or HDR-IORT”. In: Gunderson L., Willet C., Harrison L., Calvo F., Haddock M., Martinez-Monge R., et al. (eds). Current clinical oncology: intraoperative irradiation: techniques and results. New Totowa, NJ: Humana Press, 1999, 397.

[10] Tran, P.T., Z. Su, W. Hara, A. Husain, N. Teng, and D.S. Kapp: “Long-term survivors using intraoperative radiotherapy for recurrent gynecologic malignancies”. Int. J. Radiat. Oncol. Biol. Phys., 2007, 69, 504. Epub 2007 Jun 8. .

[11] Gunderson L.L., Willett C.G., Calvo F.A., Harrison L.B.: “Conclusions and future possibilities: IORT”. In: Gunderson L.L., Willet C.G., Calvo F.A., Harrison L.B. (eds). Intraoperative irradiation. techniques and results, 2nd ed. Springer, Humana Press, 2011, 503.

[12] Garton G.R., Gunderson L.L., Webb M.J., Wilson T.O., Cha S.S., Podratz K.C.: “Intraoperative radiation therapy in gynecologic cancer: update of the experience at a single institution”. Int. J. Radiat. Oncol. Biol. Phys., 1997, 37, 839.

[13] Tepper J.E., Gunderson L.L., Orlow E., Cohen A.M., Hedberg S.E., Shipley W.U., et al.: “Complications of intraoperative radiation therapy”. Int. J. Radiat. Oncol. Biol. Phys., 1984, 10, 1831.

[14] Hu K.S., Harrison L.B.: “Results and complications of surgery combined with intraoperative radiation therapy for the treatment of locally advanced or recurrent cancers in the pelvis”. Semin. Surg. Oncol., 2000, 18, 269.

[15] Poulsen M.G., Roberts S.J.: “The salvage of recurrent endometrial carcinoma in the vagina and pelvis”. Int. J. Radiat. Oncol. Biol. Phys., 1988, 15, 809.

[16] Mahe M.A., Romestaing P., Gerard J.P., Dubois J.B., Roussel A., Bussieres E., et al.: “Prognostic factors for local control in recurrent cervical carcinoma treated with IORT: report of the French IORT group”. Front. Radiat. Ther. Oncol., 1997, 31, 267.

[17] Foley O.W., Rauh-Hain J.A., del Carmen M.G.: “The role of intraoperative radiation therapy in the management of recurrent and locally advanced gynecologic cancers”. Int. J. Gynecol. Cancer, 2013, 23, 9.